Predictive Breast Cancer Gene Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Family History, Age Group, Gender); Genes Type (High Penetrant Genes, Intermediate Penetrant Genes, Low Penetrant Genes); End User (Clinical Laboratories, Cancer Hospitals, Research Laboratories)

Report Code: TIPRE00021844 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Breast cancer is highly influenced by genes and can run in families. Humans possess certain genes that are protective against cancer. However, inheriting faulty versions or variants of these genes increases the risk of developing cancer. Variants of BRCA1 and BRCA2 increases chances of developing breast cancer and ovarian cancer. Thus, predictive genetic tests are conducted to identify the variants of these genes.

MARKET DYNAMICS

The predictive breast cancer gene testing market is driving due to the increasing incidence of breast cancer, and availability of advanced technologically and treatment options. Moreover, growing awareness regarding breast cancer among the population in developed as well as developing countries is likely to create growth opportunities in the market.

MARKET SCOPE

The "Predictive Breast Cancer Gene Testing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of predictive breast cancer gene testing market with detailed market segmentation by type, gene types and end user. The predictive breast cancer gene testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in predictive breast cancer gene testing market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The predictive breast cancer gene testing market is segmented on the basis of type, gene types and end user. Based on type the market is segmented family history, age group, and gender. Gene types segment is segmented into high penetrant genes, intermediate penetrant genes, and low penetrant genes. Based on end user the market is segmented into clinical laboratories, cancer hospitals, and research laboratories.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the predictive breast cancer gene testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The predictive breast cancer gene testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting predictive breast cancer gene testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Predictive Breast Cancer Gene Testing market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the predictive breast cancer gene testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from predictive breast cancer gene testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for predictive breast cancer gene testing in the global market. Below mentioned is the list of few companies engaged in the predictive breast cancer gene testing market.

The report also includes the profiles of key players in predictive breast cancer gene testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Roche
  •   Thermo Fisher Scientific
  •   PerkinElmer
  •   Quest Diagnostics
  •   Myriad Genetics
  •   Iverson Genetics
  •   Cancer Genetics
  •   OncoCyte Corporation
  •   NeoGenomics
  •   Invitae

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Predictive Breast Cancer Gene Testing Market - By Type
1.3.2 Predictive Breast Cancer Gene Testing Market - By Genes Type
1.3.3 Predictive Breast Cancer Gene Testing Market - By End User
1.3.4 Predictive Breast Cancer Gene Testing Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PREDICTIVE BREAST CANCER GENE TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PREDICTIVE BREAST CANCER GENE TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PREDICTIVE BREAST CANCER GENE TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. PREDICTIVE BREAST CANCER GENE TESTING - GLOBAL MARKET OVERVIEW
6.2. PREDICTIVE BREAST CANCER GENE TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. PREDICTIVE BREAST CANCER GENE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. FAMILY HISTORY
7.3.1. Overview
7.3.2. Family History Market Forecast and Analysis
7.4. AGE GROUP
7.4.1. Overview
7.4.2. Age Group Market Forecast and Analysis
7.5. GENDER
7.5.1. Overview
7.5.2. Gender Market Forecast and Analysis
8. PREDICTIVE BREAST CANCER GENE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - GENES TYPE
8.1. OVERVIEW
8.2. GENES TYPE MARKET FORECASTS AND ANALYSIS
8.3. HIGH PENETRANT GENES
8.3.1. Overview
8.3.2. High Penetrant Genes Market Forecast and Analysis
8.4. INTERMEDIATE PENETRANT GENES
8.4.1. Overview
8.4.2. Intermediate Penetrant Genes Market Forecast and Analysis
8.5. LOW PENETRANT GENES
8.5.1. Overview
8.5.2. Low Penetrant Genes Market Forecast and Analysis
9. PREDICTIVE BREAST CANCER GENE TESTING MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. CLINICAL LABORATORIES
9.3.1. Overview
9.3.2. Clinical Laboratories Market Forecast and Analysis
9.4. CANCER HOSPITALS
9.4.1. Overview
9.4.2. Cancer Hospitals Market Forecast and Analysis
9.5. RESEARCH LABORATORIES
9.5.1. Overview
9.5.2. Research Laboratories Market Forecast and Analysis
10. PREDICTIVE BREAST CANCER GENE TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Predictive Breast Cancer Gene Testing Market Overview
10.1.2 North America Predictive Breast Cancer Gene Testing Market Forecasts and Analysis
10.1.3 North America Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Type
10.1.4 North America Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Genes Type
10.1.5 North America Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By End User
10.1.6 North America Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Countries
10.1.6.1 United States Predictive Breast Cancer Gene Testing Market
10.1.6.1.1 United States Predictive Breast Cancer Gene Testing Market by Type
10.1.6.1.2 United States Predictive Breast Cancer Gene Testing Market by Genes Type
10.1.6.1.3 United States Predictive Breast Cancer Gene Testing Market by End User
10.1.6.2 Canada Predictive Breast Cancer Gene Testing Market
10.1.6.2.1 Canada Predictive Breast Cancer Gene Testing Market by Type
10.1.6.2.2 Canada Predictive Breast Cancer Gene Testing Market by Genes Type
10.1.6.2.3 Canada Predictive Breast Cancer Gene Testing Market by End User
10.1.6.3 Mexico Predictive Breast Cancer Gene Testing Market
10.1.6.3.1 Mexico Predictive Breast Cancer Gene Testing Market by Type
10.1.6.3.2 Mexico Predictive Breast Cancer Gene Testing Market by Genes Type
10.1.6.3.3 Mexico Predictive Breast Cancer Gene Testing Market by End User
10.2. EUROPE
10.2.1 Europe Predictive Breast Cancer Gene Testing Market Overview
10.2.2 Europe Predictive Breast Cancer Gene Testing Market Forecasts and Analysis
10.2.3 Europe Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Type
10.2.4 Europe Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Genes Type
10.2.5 Europe Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By End User
10.2.6 Europe Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Predictive Breast Cancer Gene Testing Market
10.2.6.1.1 Germany Predictive Breast Cancer Gene Testing Market by Type
10.2.6.1.2 Germany Predictive Breast Cancer Gene Testing Market by Genes Type
10.2.6.1.3 Germany Predictive Breast Cancer Gene Testing Market by End User
10.2.6.2 France Predictive Breast Cancer Gene Testing Market
10.2.6.2.1 France Predictive Breast Cancer Gene Testing Market by Type
10.2.6.2.2 France Predictive Breast Cancer Gene Testing Market by Genes Type
10.2.6.2.3 France Predictive Breast Cancer Gene Testing Market by End User
10.2.6.3 Italy Predictive Breast Cancer Gene Testing Market
10.2.6.3.1 Italy Predictive Breast Cancer Gene Testing Market by Type
10.2.6.3.2 Italy Predictive Breast Cancer Gene Testing Market by Genes Type
10.2.6.3.3 Italy Predictive Breast Cancer Gene Testing Market by End User
10.2.6.4 Spain Predictive Breast Cancer Gene Testing Market
10.2.6.4.1 Spain Predictive Breast Cancer Gene Testing Market by Type
10.2.6.4.2 Spain Predictive Breast Cancer Gene Testing Market by Genes Type
10.2.6.4.3 Spain Predictive Breast Cancer Gene Testing Market by End User
10.2.6.5 United Kingdom Predictive Breast Cancer Gene Testing Market
10.2.6.5.1 United Kingdom Predictive Breast Cancer Gene Testing Market by Type
10.2.6.5.2 United Kingdom Predictive Breast Cancer Gene Testing Market by Genes Type
10.2.6.5.3 United Kingdom Predictive Breast Cancer Gene Testing Market by End User
10.2.6.6 Rest of Europe Predictive Breast Cancer Gene Testing Market
10.2.6.6.1 Rest of Europe Predictive Breast Cancer Gene Testing Market by Type
10.2.6.6.2 Rest of Europe Predictive Breast Cancer Gene Testing Market by Genes Type
10.2.6.6.3 Rest of Europe Predictive Breast Cancer Gene Testing Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Predictive Breast Cancer Gene Testing Market Overview
10.3.2 Asia-Pacific Predictive Breast Cancer Gene Testing Market Forecasts and Analysis
10.3.3 Asia-Pacific Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Genes Type
10.3.5 Asia-Pacific Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Predictive Breast Cancer Gene Testing Market
10.3.6.1.1 Australia Predictive Breast Cancer Gene Testing Market by Type
10.3.6.1.2 Australia Predictive Breast Cancer Gene Testing Market by Genes Type
10.3.6.1.3 Australia Predictive Breast Cancer Gene Testing Market by End User
10.3.6.2 China Predictive Breast Cancer Gene Testing Market
10.3.6.2.1 China Predictive Breast Cancer Gene Testing Market by Type
10.3.6.2.2 China Predictive Breast Cancer Gene Testing Market by Genes Type
10.3.6.2.3 China Predictive Breast Cancer Gene Testing Market by End User
10.3.6.3 India Predictive Breast Cancer Gene Testing Market
10.3.6.3.1 India Predictive Breast Cancer Gene Testing Market by Type
10.3.6.3.2 India Predictive Breast Cancer Gene Testing Market by Genes Type
10.3.6.3.3 India Predictive Breast Cancer Gene Testing Market by End User
10.3.6.4 Japan Predictive Breast Cancer Gene Testing Market
10.3.6.4.1 Japan Predictive Breast Cancer Gene Testing Market by Type
10.3.6.4.2 Japan Predictive Breast Cancer Gene Testing Market by Genes Type
10.3.6.4.3 Japan Predictive Breast Cancer Gene Testing Market by End User
10.3.6.5 South Korea Predictive Breast Cancer Gene Testing Market
10.3.6.5.1 South Korea Predictive Breast Cancer Gene Testing Market by Type
10.3.6.5.2 South Korea Predictive Breast Cancer Gene Testing Market by Genes Type
10.3.6.5.3 South Korea Predictive Breast Cancer Gene Testing Market by End User
10.3.6.6 Rest of Asia-Pacific Predictive Breast Cancer Gene Testing Market
10.3.6.6.1 Rest of Asia-Pacific Predictive Breast Cancer Gene Testing Market by Type
10.3.6.6.2 Rest of Asia-Pacific Predictive Breast Cancer Gene Testing Market by Genes Type
10.3.6.6.3 Rest of Asia-Pacific Predictive Breast Cancer Gene Testing Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Predictive Breast Cancer Gene Testing Market Overview
10.4.2 Middle East and Africa Predictive Breast Cancer Gene Testing Market Forecasts and Analysis
10.4.3 Middle East and Africa Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Genes Type
10.4.5 Middle East and Africa Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Predictive Breast Cancer Gene Testing Market
10.4.6.1.1 South Africa Predictive Breast Cancer Gene Testing Market by Type
10.4.6.1.2 South Africa Predictive Breast Cancer Gene Testing Market by Genes Type
10.4.6.1.3 South Africa Predictive Breast Cancer Gene Testing Market by End User
10.4.6.2 Saudi Arabia Predictive Breast Cancer Gene Testing Market
10.4.6.2.1 Saudi Arabia Predictive Breast Cancer Gene Testing Market by Type
10.4.6.2.2 Saudi Arabia Predictive Breast Cancer Gene Testing Market by Genes Type
10.4.6.2.3 Saudi Arabia Predictive Breast Cancer Gene Testing Market by End User
10.4.6.3 U.A.E Predictive Breast Cancer Gene Testing Market
10.4.6.3.1 U.A.E Predictive Breast Cancer Gene Testing Market by Type
10.4.6.3.2 U.A.E Predictive Breast Cancer Gene Testing Market by Genes Type
10.4.6.3.3 U.A.E Predictive Breast Cancer Gene Testing Market by End User
10.4.6.4 Rest of Middle East and Africa Predictive Breast Cancer Gene Testing Market
10.4.6.4.1 Rest of Middle East and Africa Predictive Breast Cancer Gene Testing Market by Type
10.4.6.4.2 Rest of Middle East and Africa Predictive Breast Cancer Gene Testing Market by Genes Type
10.4.6.4.3 Rest of Middle East and Africa Predictive Breast Cancer Gene Testing Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Predictive Breast Cancer Gene Testing Market Overview
10.5.2 South and Central America Predictive Breast Cancer Gene Testing Market Forecasts and Analysis
10.5.3 South and Central America Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Type
10.5.4 South and Central America Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Genes Type
10.5.5 South and Central America Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By End User
10.5.6 South and Central America Predictive Breast Cancer Gene Testing Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Predictive Breast Cancer Gene Testing Market
10.5.6.1.1 Brazil Predictive Breast Cancer Gene Testing Market by Type
10.5.6.1.2 Brazil Predictive Breast Cancer Gene Testing Market by Genes Type
10.5.6.1.3 Brazil Predictive Breast Cancer Gene Testing Market by End User
10.5.6.2 Argentina Predictive Breast Cancer Gene Testing Market
10.5.6.2.1 Argentina Predictive Breast Cancer Gene Testing Market by Type
10.5.6.2.2 Argentina Predictive Breast Cancer Gene Testing Market by Genes Type
10.5.6.2.3 Argentina Predictive Breast Cancer Gene Testing Market by End User
10.5.6.3 Rest of South and Central America Predictive Breast Cancer Gene Testing Market
10.5.6.3.1 Rest of South and Central America Predictive Breast Cancer Gene Testing Market by Type
10.5.6.3.2 Rest of South and Central America Predictive Breast Cancer Gene Testing Market by Genes Type
10.5.6.3.3 Rest of South and Central America Predictive Breast Cancer Gene Testing Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PREDICTIVE BREAST CANCER GENE TESTING MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PREDICTIVE BREAST CANCER GENE TESTING MARKET, KEY COMPANY PROFILES
13.1. MYRIAD GENETICS, INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. COMPLETE GENOMICS INCORPORATED
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. AMBRY GENETICS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. PREVENTIONGENETICS
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ILLUMINA, INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. F. HOFFMANN-LA ROCHE AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. THERMO FISHER SCIENTIFIC
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. PERKINELMER
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. QUEST DIAGNOSTICS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. NEOGENOMICS
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Roche
2. Thermo Fisher Scientific
3. PerkinElmer
4. Quest Diagnostics
5. Myriad Genetics
6. Iverson Genetics
7. Cancer Genetics
8. OncoCyte Corporation
9. NeoGenomics
10. Invitae
TIPRE00021844
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking